Swedish Pharmaceuticals & Biotech Price disconnect

Results

0 new

Stocks which the market has priced substantially different to their cash flows, which could imply risk.

3 companies

Swedencare

Market Cap: SEK 3.4b

Develops, manufactures, markets, and sells animal healthcare products for cats, dogs, and horses in North America, Europe, and internationally.

SECARE

SEK 21.50

0.2%

-40.5%

Cantargia

Market Cap: SEK 451.0m

A biotechnology company, develops pharmaceuticals for treatment of cancer, inflammatory, and autoimmune diseases.

CANTA

SEK 1.80

-1.6%

-36.8%

Sprint Bioscience

Market Cap: SEK 351.4m

A pharmaceutical company, engages in the development of drug candidates to treat cancer in Sweden.

SPRINT

SEK 3.37

-2.0%

456.1%